Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria

D Tews1, S Lehr, S Hartwig

  • 1Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Düsseldorf, Germany.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|December 17, 2008
PubMed

Insights

Glucagon-like peptide-1 (GLP-1) mimetics like exendin-4 protect pancreatic beta cells from apoptosis by preventing mitochondrial damage and reducing oxidative stress. This study reveals exendin-4 counter-regulates electron transport chain protein loss, contributing to its anti-apoptotic effects.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Endocrinology

Background:

  • Glucagon-like peptide-1 (GLP-1) enhances beta cell mass through proliferation and apoptosis inhibition.
  • The exact mechanism behind GLP-1's anti-apoptotic effect, particularly with mimetics like exendin-4, is not fully understood.

Purpose of the Study:

  • To investigate the anti-apoptotic mechanism of exendin-4 in cytokine-treated pancreatic beta cells.
  • To analyze mitochondrial protein alterations in response to cytokine-induced apoptosis and exendin-4 treatment.

Main Methods:

  • Utilized the INS-1 pancreatic beta cell line for cytokine-induced apoptosis studies.
  • Performed comparative mitochondrial proteome analysis using two-dimensional difference gel electrophoresis (2D-DIGE).
  • Identified significantly altered protein spots using MALDI mass spectrometry.

Main Results:

  • Cytokine incubation increased caspase-3 activity, an effect reduced by 60% with exendin-4.
  • Exendin-4 completely prevented cytokine-induced reactive oxygen species production.
  • Mitochondrial proteome analysis identified 33 altered proteins, revealing cytokine-induced electron transport chain damage (e.g., downregulation of cytochrome bc1 complex subunit I and ATP synthase subunit beta), which was abrogated by exendin-4.

Conclusions:

  • Mitochondria play a crucial role in cytokine-induced apoptosis of pancreatic beta cells.
  • Exendin-4 counter-regulates the downregulation of electron transport chain proteins.
  • This action of exendin-4 reduces oxidative stress, likely contributing to its anti-apoptotic effects.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...